Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 10/20 | 0.54 |
| ▸ | ESR2 | Q92731 | 10/20 | 0.54 |
| ▸ | HSD17B1 | P14061 | 7/20 | 0.49 |
| ▸ | HSD17B2 | P37059 | 7/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.49 |
| ▸ | CYP2B6 | P20813 | 3/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.49 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.42 |
| ▸ | MPL | P40238 | 1/20 | 0.40 |
| ▸ | CDK4 | P11802 | 1/20 | 0.39 |
| ▸ | CCND1 | P24385 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23861415 | 0.94 | ESR1 (0.47) | ESR1ESR2HSD17B1HSD17B2CYP1A2 | |
| SCHEMBL23861442 | 0.91 | ESR2 (0.49) | ESR1ESR2HSD17B1HSD17B2CYP1A2 | |
| SCHEMBL23082042 | 0.90 | ESR1 (0.48) | ESR1ESR2HSD17B1HSD17B2CYP1A2 | |
| SCHEMBL19806908 | 0.90 | ESR1 (0.47) | ESR1ESR2HSD17B1HSD17B2CYP1A2 | |
| SCHEMBL23861565 | 0.90 | ESR1 (0.40) | ESR1ESR2HSD17B1HSD17B2CYP1A2 | |
| SCHEMBL19803933 | 0.88 | ESR1 (0.45) | ESR1ESR2HSD17B1HSD17B2CYP1A2 | |
| SCHEMBL19803934 | 0.85 | ESR1 (0.42) | ESR1ESR2HSD17B2CYP1A2CYP2D6 | |
| SCHEMBL23861639 | 0.84 | CYP1A2 (0.49) | ESR1ESR2HSD17B1HSD17B2CYP1A2 | |
| SCHEMBL23861411 | 0.84 | ESR1 (0.41) | ESR1ESR2HSD17B1HSD17B2CYP1A2 | |
| SCHEMBL23861559 | 0.82 | PTPN22 (0.44) | ESR1ESR2HSD17B2CYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11130724-B2 | Compound, resin, composition, resist pattern formation method, and circuit pattern formation method | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2021-09-28 | — | — | US | disclosed |
| US-20210070727-A1 | COMPOUND, RESIN, COMPOSITION AND PATTERN FORMATION METHOD | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2021-03-11 | — | — | US | disclosed |
| US-20210070683-A1 | COMPOUND, RESIN, COMPOSITION, RESIST PATTERN FORMATION METHOD AND CIRCUIT PATTERN FORMATION METHOD | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2021-03-11 | — | — | US | disclosed |
| US-20210070685-A1 | COMPOUND, RESIN, COMPOSITION, RESIST PATTERN FORMATION METHOD AND CIRCUIT PATTERN FORMATION METHOD | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2021-03-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210070683-A1 | COMPOUND, RESIN, COMPOSITION, RESIST PATTERN FORMATION METHOD AND CIRCUIT PATTERN FORMATION METHOD | RER1, RTN4, FEM1B | ESR1 1539/4885ESR2 2068/4885HSD17B1 3543/4885 |
| US-20210070727-A1 | COMPOUND, RESIN, COMPOSITION AND PATTERN FORMATION METHOD | RDX, RTN4, CROCC | ESR1 1453/4885ESR2 1492/4885HSD17B1 2357/4885 |
| US-20210070685-A1 | COMPOUND, RESIN, COMPOSITION, RESIST PATTERN FORMATION METHOD AND CIRCUIT PATTERN FORMATION METHOD | RER1, RTN4, FEM1B | ESR1 1539/4885ESR2 2068/4885HSD17B1 3543/4885 |
| US-11130724-B2 | Compound, resin, composition, resist pattern formation method, and circuit pattern formation method | RER1, NBAS, INTS9 | ESR1 713/4885ESR2 1033/4885HSD17B1 1116/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.